News
How to Make an Artificial Cell
June 13, 2010 8:39 pm | by Massachusetts Institute of Technology | CommentsResearchers at the Venter Institute explain their groundbreaking techniques.
Old Livers Made New Again
June 13, 2010 8:39 pm | by Massachusetts Institute of Technology | CommentsUnhealthy organs provide a framework for growing replacement ones.
Study reveals causes of survival disparities based on insurance among rectal cancer patients
June 13, 2010 8:37 pm | by EurekAlert | Comments(American Cancer Society) Disparities in cancer stage and treatment are the main reasons why Medicaid-insured and uninsured rectal cancer patients are twice as likely to die within five years as privately insured patients.
Cost concerns prevent many cancer survivors from getting medical care
June 13, 2010 8:37 pm | by EurekAlert | Comments(American Cancer Society) A new analysis has found that two million cancer survivors did not get needed medical services in the previous year because of concerns about cost.
Robotic Surgery: Medicine or Marketing?
June 13, 2010 7:41 pm | by Bio-Medicine.Org | CommentsAn Ethical and Clinical Exploration of the Pros & Cons of Robotic Surgery PHILADELPHIA , June 11 /PRNewswire-USNewswire/ -- Robotic surgery -- is it truly an advance for modern medicine, or just a product of slick consumer advertising campaigns and targeted marketing to physicians?...
Questcor Receives Notification of PDUFA Date Extension to September 11, 2010
June 13, 2010 7:39 pm | by Bio-Medicine.Org | CommentsUNION CITY, Calif. , June 11 /- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR ) today announced that it has received notification from the U.S. Food & Drug Administration (FDA) that the PDUFA date for Questcor's supplemental new drug application (sNDA) to approve Acthar for the...
Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
June 13, 2010 7:37 pm | by Bio-Medicine.Org | CommentsRIDGEFIELD, Conn. , June 13 /- Telmisartan, an angiotensin receptor blocker, is one of the best researched drugs worldwide. It has been studied in clinical trials in more than 50,000 patients. Its positive safety profile has been confirmed also in a market exposure of 34.5 million patient...
Medical Device and Diagnostic Industry Names Envoy Medical a Company to Watch
June 13, 2010 7:37 pm | by Bio-Medicine.Org | CommentsSAINT PAUL, Minn. , June 11 /- Envoy Medical Corporation has been named by Medical Device and Diagnostic Industry as one of the "50 Companies to Watch" in the medical device industry. Medical Device and Diagnostic Industry ("MD+DI"), a monthly magazine dedicated to the medical device and...
Zargis to Launch FDA-Cleared Lung Sounds Analysis Technology from Stethographics, Inc.
June 13, 2010 7:37 pm | by Bio-Medicine.Org | CommentsSTAMFORD, Conn. , June 11 /- Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp. (Nasdaq: SPDE ), today announced that it has entered into an agreement with Boston -based Stethographics, Inc. providing an exclusive license to patented, FDA-cleared Stethographics lung sounds...
Children born after assisted reproduction at greater risk of congenital malformations
June 13, 2010 2:40 pm | by EurekAlert | Comments(European Society of Human Genetics) Couples considering undergoing assisted reproductive technology (ART) treatment should be informed about the increased risk of congenital malformation posed by the use of ART.
University Hospitals Case Medical Center cardiologists discover cancer risks in blood pressure meds
June 13, 2010 2:37 pm | by EurekAlert | Comments(University Hospitals Case Medical Center) University Hospitals Case Medical Center cardiologists have uncovered new research showing an increased risk of cancer with a group of blood pressure medications known as angiotensin-receptor blockers (ARBs). This class of drugs is used by...
Small genetic variant can predict response to hepatitis C treatment
June 12, 2010 2:42 pm | by EurekAlert | Comments(European Society of Human Genetics) A small genetic change can predict how people infected with hepatitis C react to treatment, paving the way to personalized therapy for this difficult-to-treat disease.
Summary Information for: Ethicon? OMNEX? Surgical Sealant (250 & mu;l)
June 12, 2010 3:38 am | by U.S. Food & Drug Administration | CommentsLabeling, Approval Order, and Summary of Safety and Effectiveness for Ethicon? OMNEX? Surgical Sealant (250μl) (P060029).
FDA: Design Control Issues Remain Major Quality Assurance Concern
June 11, 2010 1:40 pm | by U.S. Food & Drug Administration | CommentsAlthough design control issues have not been cited often in recent warning letters, they remain a big concern for the FDA.
Cochlear Manufacturer Will Pay Nearly $1 Million to End Probe
June 11, 2010 1:40 pm | by U.S. Food & Drug Administration | CommentsA manufacturer of cochlear implants will pay nearly $1 million to resolve Justice Department claims that it paid kickbacks to physicians to prescribe its electronic hearing devices to Medicare and Medicaid patients from 1998 to 2003.
